Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Parental age and risk of genetic syndromes predisposing to nervous system tumors: nested case-control study.

Adel Fahmideh M, Tettamanti G, Lavebratt C, Talbäck M, Mathiesen T, Lannering B, Johnson KJ, Feychting M.

Clin Epidemiol. 2018 Jun 20;10:729-738. doi: 10.2147/CLEP.S159183. eCollection 2018.

2.

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernáiz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schüz J, Johansen C, Andersen TV, Röösli M, Kuehni CE, Grotzer M, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM.

Lancet Oncol. 2018 Jun;19(6):785-798. doi: 10.1016/S1470-2045(18)30242-0. Epub 2018 May 9.

3.

Information needs of survivors and families after childhood CNS tumor treatment: a population-based study.

Hovén E, Lannering B, Gustafsson G, Boman KK.

Acta Oncol. 2018 May;57(5):649-657. doi: 10.1080/0284186X.2017.1406136. Epub 2017 Dec 1.

PMID:
29191069
4.

Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures.

Schwalbe EC, Hicks D, Rafiee G, Bashton M, Gohlke H, Enshaei A, Potluri S, Matthiesen J, Mather M, Taleongpong P, Chaston R, Silmon A, Curtis A, Lindsey JC, Crosier S, Smith AJ, Goschzik T, Doz F, Rutkowski S, Lannering B, Pietsch T, Bailey S, Williamson D, Clifford SC.

Sci Rep. 2017 Oct 18;7(1):13421. doi: 10.1038/s41598-017-13644-1.

5.

Correction: A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Tomić TT, Olausson J, Wilzén A, Sabel M, Truvé K, Sjögren H, Dósa S, Tisell M, Lannering B, Enlund F, Martinsson T, Åman P, Abel F.

PLoS One. 2017 Sep 7;12(9):e0184715. doi: 10.1371/journal.pone.0184715. eCollection 2017.

6.

Hypothermia after cranial irradiation protects neural progenitor cells in the subventricular zone but not in the hippocampus.

Sabel M, Kalm M, Björk-Eriksson T, Lannering B, Blomgren K.

Int J Radiat Biol. 2017 Aug;93(8):771-783. doi: 10.1080/09553002.2017.1321810. Epub 2017 May 24.

PMID:
28452566
7.

A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma.

Tomić TT, Olausson J, Wilzén A, Sabel M, Truvé K, Sjögren H, Dósa S, Tisell M, Lannering B, Enlund F, Martinsson T, Åman P, Abel F.

PLoS One. 2017 Apr 27;12(4):e0175638. doi: 10.1371/journal.pone.0175638. eCollection 2017. Erratum in: PLoS One. 2017 Sep 7;12 (9):e0184715.

8.

Stem cell cultures derived from pediatric brain tumors accurately model the originating tumors.

Wenger A, Larsson S, Danielsson A, Elbæk KJ, Kettunen P, Tisell M, Sabel M, Lannering B, Nordborg C, Schepke E, Carén H.

Oncotarget. 2017 Mar 21;8(12):18626-18639. doi: 10.18632/oncotarget.14826.

9.

Prenatal and Postnatal Medical Conditions and the Risk of Brain Tumors in Children and Adolescents: An International Multicenter Case-Control Study.

Tettamanti G, Shu X, Adel Fahmideh M, Schüz J, Röösli M, Tynes T, Grotzer M, Johansen C, Klaeboe L, Kuehni CE, Lannering B, Schmidt LS, Vienneau D, Feychting M.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):110-115. doi: 10.1158/1055-9965.EPI-16-0451. Epub 2016 Sep 13.

10.

Common genetic variations in cell cycle and DNA repair pathways associated with pediatric brain tumor susceptibility.

Adel Fahmideh M, Lavebratt C, Schüz J, Röösli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M.

Oncotarget. 2016 Sep 27;7(39):63640-63650. doi: 10.18632/oncotarget.11575.

11.

Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study.

Sabel M, Fleischhack G, Tippelt S, Gustafsson G, Doz F, Kortmann R, Massimino M, Navajas A, von Hoff K, Rutkowski S, Warmuth-Metz M, Clifford SC, Pietsch T, Pizer B, Lannering B; SIOP-E Brain Tumour Group.

J Neurooncol. 2016 Sep;129(3):515-524. doi: 10.1007/s11060-016-2202-1. Epub 2016 Jul 16.

12.

Active video gaming improves body coordination in survivors of childhood brain tumours.

Sabel M, Sjölund A, Broeren J, Arvidsson D, Saury JM, Blomgren K, Lannering B, Emanuelson I.

Disabil Rehabil. 2016 Oct;38(21):2073-84. doi: 10.3109/09638288.2015.1116619. Epub 2016 Jan 5.

PMID:
26728453
13.

A multinational case-control study on childhood brain tumours, anthropogenic factors, birth characteristics and prenatal exposures: A validation of interview data.

Vienneau D, Infanger D, Feychting M, Schüz J, Schmidt LS, Poulsen AH, Tettamanti G, Klæboe L, Kuehni CE, Tynes T, Von der Weid N, Lannering B, Röösli M.

Cancer Epidemiol. 2016 Feb;40:52-9. doi: 10.1016/j.canep.2015.11.006. Epub 2015 Nov 25.

PMID:
26625087
14.

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.

Clifford SC, Lannering B, Schwalbe EC, Hicks D, O'Toole K, Nicholson SL, Goschzik T, Zur Mühlen A, Figarella-Branger D, Doz F, Rutkowski S, Gustafsson G, Pietsch T; SIOP-Europe PNET Group.

Oncotarget. 2015 Nov 17;6(36):38827-39. doi: 10.18632/oncotarget.5149.

15.

Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.

Câmara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M; Quality of Survival Working Group of the Brain Tumour Group of SIOP-Europe.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):978-985. doi: 10.1016/j.ijrobp.2015.04.023. Epub 2015 Apr 17.

PMID:
26194675
16.

MethPed: a DNA methylation classifier tool for the identification of pediatric brain tumor subtypes.

Danielsson A, Nemes S, Tisell M, Lannering B, Nordborg C, Sabel M, Carén H.

Clin Epigenetics. 2015 Jul 9;7:62. doi: 10.1186/s13148-015-0103-3. eCollection 2015.

17.

CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.

Adel Fahmideh M, Lavebratt C, Schüz J, Röösli M, Tynes T, Grotzer MA, Johansen C, Kuehni CE, Lannering B, Prochazka M, Schmidt LS, Feychting M.

Carcinogenesis. 2015 Aug;36(8):876-82. doi: 10.1093/carcin/bgv074. Epub 2015 May 25.

18.

Altered self-perception in adult survivors treated for a CNS tumor in childhood or adolescence: population-based outcomes compared with the general population.

Hörnquist L, Rickardsson J, Lannering B, Gustafsson G, Boman KK.

Neuro Oncol. 2015 May;17(5):733-40. doi: 10.1093/neuonc/nou289. Epub 2014 Oct 20.

19.

Cancer in children and young adults born after assisted reproductive technology: a Nordic cohort study from the Committee of Nordic ART and Safety (CoNARTaS).

Sundh KJ, Henningsen AK, Källen K, Bergh C, Romundstad LB, Gissler M, Pinborg A, Skjaerven R, Tiitinen A, Vassard D, Lannering B, Wennerholm UB.

Hum Reprod. 2014 Sep;29(9):2050-7. doi: 10.1093/humrep/deu143. Epub 2014 Jul 2.

PMID:
24990274
20.

Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma.

Porkholm M, Valanne L, Lönnqvist T, Holm S, Lannering B, Riikonen P, Wojcik D, Sehested A, Clausen N, Harila-Saari A, Schomerus E, Thorarinsdottir HK, Lähteenmäki P, Arola M, Thomassen H, Saarinen-Pihkala UM, Kivivuori SM.

Pediatr Blood Cancer. 2014 Sep;61(9):1603-9. doi: 10.1002/pbc.25045. Epub 2014 Apr 1.

PMID:
24692119
21.

Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO).

Shu X, Prochazka M, Lannering B, Schüz J, Röösli M, Tynes T, Kuehni CE, Andersen TV, Infanger D, Schmidt LS, Poulsen AH, Klaeboe L, Eggen T, Feychting M.

Ann Oncol. 2014 Apr;25(4):902-8. doi: 10.1093/annonc/mdu048. Epub 2014 Mar 7.

PMID:
24608192
22.

Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review.

Gudrunardottir T, Lannering B, Remke M, Taylor MD, Wells EM, Keating RF, Packer RJ.

Childs Nerv Syst. 2014 Jun;30(6):979-90. doi: 10.1007/s00381-014-2388-5. Epub 2014 Feb 26. Review.

PMID:
24569911
23.

Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.

Brodin NP, Munck af Rosenschöld P, Blomstrand M, Kiil-Berthlesen A, Hollensen C, Vogelius IR, Lannering B, Bentzen SM, Björk-Eriksson T.

Neuro Oncol. 2014 Apr;16(4):594-602. doi: 10.1093/neuonc/not225. Epub 2013 Dec 9.

24.

Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma.

Kennedy C, Bull K, Chevignard M, Culliford D, Dörr HG, Doz F, Kortmann RD, Lannering B, Massimino M, Navajas Gutiérrez A, Rutkowski S, Spoudeas HA, Calaminus G; PNET4 study group of the Brain Tumour Group of The European branch of the International Society of Paediatric Oncology (SIOP-E).

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):292-300. doi: 10.1016/j.ijrobp.2013.09.046. Epub 2013 Nov 13.

PMID:
24239386
25.

Patterns of exposure to infectious diseases and social contacts in early life and risk of brain tumours in children and adolescents: an International Case-Control Study (CEFALO).

Andersen TV, Schmidt LS, Poulsen AH, Feychting M, Röösli M, Tynes T, Aydin D, Prochazka M, Lannering B, Klæboe L, Eggen T, Kuehni CE, Schmiegelow K, Schüz J.

Br J Cancer. 2013 Jun 11;108(11):2346-53. doi: 10.1038/bjc.2013.201. Epub 2013 May 7.

26.

Disability, body image and sports/physical activity in adult survivors of childhood CNS tumors: population-based outcomes from a cohort study.

Boman KK, Hörnquist L, De Graaff L, Rickardsson J, Lannering B, Gustafsson G.

J Neurooncol. 2013 Mar;112(1):99-106. doi: 10.1007/s11060-012-1039-5. Epub 2013 Jan 26.

PMID:
23354653
27.

Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.

Lannering B, Rutkowski S, Doz F, Pizer B, Gustafsson G, Navajas A, Massimino M, Reddingius R, Benesch M, Carrie C, Taylor R, Gandola L, Björk-Eriksson T, Giralt J, Oldenburger F, Pietsch T, Figarella-Branger D, Robson K, Forni M, Clifford SC, Warmuth-Metz M, von Hoff K, Faldum A, Mosseri V, Kortmann R.

J Clin Oncol. 2012 Sep 10;30(26):3187-93. doi: 10.1200/JCO.2011.39.8719. Epub 2012 Jul 30.

PMID:
22851561
28.

Brain tumors in children and adolescents and exposure to animals and farm life: a multicenter case-control study (CEFALO).

Christensen JS, Mortensen LH, Röösli M, Feychting M, Tynes T, Andersen TV, Schmidt LS, Poulsen AH, Aydin D, Kuehni CE, Prochazka M, Lannering B, Klaeboe L, Eggen T, Schüz J.

Cancer Causes Control. 2012 Sep;23(9):1463-73. doi: 10.1007/s10552-012-0020-0. Epub 2012 Jul 12.

PMID:
22790303
29.

Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma.

Blomstrand M, Brodin NP, Munck Af Rosenschöld P, Vogelius IR, Sánchez Merino G, Kiil-Berthlesen A, Blomgren K, Lannering B, Bentzen SM, Björk-Eriksson T.

Neuro Oncol. 2012 Jul;14(7):882-9. doi: 10.1093/neuonc/nos120. Epub 2012 May 17.

30.

Persistent impact of illness on families of adult survivors of childhood central nervous system tumors: a population-based cohort study.

Hovén EI, Lannering B, Gustafsson G, Boman KK.

Psychooncology. 2013 Jan;22(1):160-7. doi: 10.1002/pon.2067. Epub 2011 Sep 22.

PMID:
21948459
31.

Mobile phone use and brain tumors in children and adolescents: a multicenter case-control study.

Aydin D, Feychting M, Schüz J, Tynes T, Andersen TV, Schmidt LS, Poulsen AH, Johansen C, Prochazka M, Lannering B, Klæboe L, Eggen T, Jenni D, Grotzer M, Von der Weid N, Kuehni CE, Röösli M.

J Natl Cancer Inst. 2011 Aug 17;103(16):1264-76. doi: 10.1093/jnci/djr244. Epub 2011 Jul 27.

PMID:
21795665
32.

Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.

Brodin NP, Munck Af Rosenschöld P, Aznar MC, Kiil-Berthelsen A, Vogelius IR, Nilsson P, Lannering B, Björk-Eriksson T.

Acta Oncol. 2011 Aug;50(6):806-16. doi: 10.3109/0284186X.2011.582514.

PMID:
21767178
33.

The met and unmet health care needs of adult survivors of childhood central nervous system tumors: a double-informant, population-based study.

Hovén E, Lannering B, Gustafsson G, Boman KK.

Cancer. 2011 Sep 15;117(18):4294-303. doi: 10.1002/cncr.26020. Epub 2011 Mar 8.

34.

[High survival after childhood cancer, sometimes at a high price].

Hjorth L, Arvidson J, Behrendtz M, Garwicz S, Jarfelt M, Lannering B, Martinsson U, Melin B, Petersen C, Sandström PE, Söderhäll S.

Lakartidningen. 2010 Oct 20-26;107(42):2572-5. Review. Swedish. No abstract available.

PMID:
21137552
35.

Irradiation to the immature brain attenuates neurogenesis and exacerbates subsequent hypoxic-ischemic brain injury in the adult.

Zhu C, Huang Z, Gao J, Zhang Y, Wang X, Karlsson N, Li Q, Lannering B, Björk-Eriksson T, Georg Kuhn H, Blomgren K.

J Neurochem. 2009 Dec;111(6):1447-56. doi: 10.1111/j.1471-4159.2009.06413.x. Epub 2009 Oct 3.

36.

Health and persistent functional late effects in adult survivors of childhood CNS tumours: a population-based cohort study.

Boman KK, Hovén E, Anclair M, Lannering B, Gustafsson G.

Eur J Cancer. 2009 Sep;45(14):2552-61. doi: 10.1016/j.ejca.2009.06.008. Epub 2009 Jul 16.

PMID:
19616428
37.

Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984-2005.

Lannering B, Sandström PE, Holm S, Lundgren J, Pfeifer S, Samuelsson U, Strömberg B, Gustafsson G; Swedish Childhood CNS Tumor Working Group (VCTB).

Acta Paediatr. 2009 Oct;98(10):1620-7. doi: 10.1111/j.1651-2227.2009.01417.x. Epub 2009 Jul 7.

PMID:
19594464
38.

Parental fears following their child's brain tumor diagnosis and treatment.

Anclair M, Hovén E, Lannering B, Boman KK.

J Pediatr Oncol Nurs. 2009 Mar-Apr;26(2):68-74. doi: 10.1177/1043454208323912. Epub 2009 Feb 3.

PMID:
19190177
39.

Transient inflammation in neurogenic regions after irradiation of the developing brain.

Kalm M, Fukuda A, Fukuda H, Ohrfelt A, Lannering B, Björk-Eriksson T, Blennow K, Márky I, Blomgren K.

Radiat Res. 2009 Jan;171(1):66-76. doi: 10.1667/RR1269.1.

PMID:
19138045
40.

Irradiation-induced loss of microglia in the young brain.

Kalm M, Lannering B, Björk-Eriksson T, Blomgren K.

J Neuroimmunol. 2009 Jan 3;206(1-2):70-5. doi: 10.1016/j.jneuroim.2008.11.002. Epub 2008 Dec 13.

PMID:
19070908
41.

X chromosome-linked inhibitor of apoptosis protein reduces oxidative stress after cerebral irradiation or hypoxia-ischemia through up-regulation of mitochondrial antioxidants.

Zhu C, Xu F, Fukuda A, Wang X, Fukuda H, Korhonen L, Hagberg H, Lannering B, Nilsson M, Eriksson PS, Northington FJ, Björk-Eriksson T, Lindholm D, Blomgren K.

Eur J Neurosci. 2007 Dec;26(12):3402-10. Epub 2007 Dec 4.

PMID:
18052985
42.

Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.

Osterlundh G, Kjellmer I, Lannering B, Rosengren L, Nilsson UA, Márky I.

Pediatr Blood Cancer. 2008 Apr;50(4):793-8.

PMID:
17973312
43.

Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia.

Jarfelt M, Kujacic V, Holmgren D, Bjarnason R, Lannering B.

Pediatr Blood Cancer. 2007 Nov;49(6):835-40.

PMID:
17610264
44.

Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia.

Jarfelt M, Fors H, Lannering B, Bjarnason R.

Eur J Endocrinol. 2006 Feb;154(2):303-9.

45.

Progenitor cell injury after irradiation to the developing brain can be modulated by mild hypothermia or hyperthermia.

Fukuda A, Fukuda H, Jönsson M, Swanpalmer J, Hertzman S, Lannering B, Björk-Eriksson T, Màrky I, Blomgren K.

J Neurochem. 2005 Sep;94(6):1604-19. Epub 2005 Aug 8.

46.

Body composition in young adult survivors of childhood acute lymphoblastic leukaemia.

Jarfelt M, Lannering B, Bosaeus I, Johannsson G, Bjarnason R.

Eur J Endocrinol. 2005 Jul;153(1):81-9.

47.

Age-dependent sensitivity of the developing brain to irradiation is correlated with the number and vulnerability of progenitor cells.

Fukuda A, Fukuda H, Swanpalmer J, Hertzman S, Lannering B, Marky I, Björk-Eriksson T, Blomgren K.

J Neurochem. 2005 Feb;92(3):569-84. Erratum in: J Neurochem. 2005 Dec;95(6):1802.

48.

Irradiation-induced progenitor cell death in the developing brain is resistant to erythropoietin treatment and caspase inhibition.

Fukuda H, Fukuda A, Zhu C, Korhonen L, Swanpalmer J, Hertzman S, Leist M, Lannering B, Lindholm D, Björk-Eriksson T, Marky I, Blomgren K.

Cell Death Differ. 2004 Nov;11(11):1166-78.

49.

Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation.

Jarfelt M, Bjarnason R, Lannering B.

Pediatr Blood Cancer. 2004 Jun;42(7):582-8.

PMID:
15127412
50.

Prepubertal growth and growth hormone secretion in children after treatment for hematological malignancies, including autologous bone marrow transplantation.

Arvidson J, Lönnerholm G, Tuvemo T, Carlson K, Lannering B, Lönnerholm T.

Pediatr Hematol Oncol. 2000 Jun;17(4):285-97.

PMID:
10845227

Supplemental Content

Loading ...
Support Center